Drugs / Recombinant fimbrial adhesin dscCfaE
Recombinant fimbrial adhesin dscCfaE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01644565 | Aug 2012 → Jun 2014 | escherichia coli infection | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant fimbrial adhesin dscCfaE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01644565 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant fimbrial adhesin dscCfaE” NCT01644565 ↗ |
| Route | Other | “by intradermal (ID) immunization” NCT01644565 ↗ |